A detailed history of Pnc Financial Services Group, Inc. transactions in Enzo Biochem Inc stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 700 shares of ENZ stock, worth $385. This represents 0.0% of its overall portfolio holdings.

Number of Shares
700
Holding current value
$385
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025

BUY
$0.7 - $1.17 $489 - $819
700 New
700 $0
Q4 2018

Feb 08, 2019

SELL
$2.46 - $4.2 $450 - $768
-183 Closed
0 $0
Q3 2018

Nov 09, 2018

SELL
$3.81 - $5.53 $6,922 - $10,048
-1,817 Reduced 90.85%
183 $0
Q2 2018

Aug 10, 2018

BUY
$5.06 - $6.78 $10,120 - $13,560
2,000 New
2,000 $0

Others Institutions Holding ENZ

About ENZO BIOCHEM INC


  • Ticker ENZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 48,720,500
  • Market Cap $26.8M
  • Description
  • Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...
More about ENZ
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.